Quick answer: For a sustained, high-volume refill backlog, automation clears it more reliably than hiring. Adding staff scales linearly with volume and carries turnover risk, while a refill processing platform absorbs the routine renewals at near-zero marginal cost and only escalates the exceptions a human actually needs to touch. Hiring still wins for short-term spikes or very low volume; for a chronic backlog driven by steady refill load, automation is the structural fix and staff are best aimed at the exceptions.
What's actually driving your refill backlog
Before choosing a fix, name the cause. A refill backlog is rarely a one-time event — it's the predictable result of steady volume hitting a fixed amount of staff time. A full-time primary care physician fields between 10 and 25 refill requests a day and spends roughly 30 minutes daily on them. Across a multi-provider panel, that's several staff-hours a day of pure refill handling, every day.
The backlog forms when that steady load outruns the hours your team can give it — and it gets worse exactly when you can least afford it, during PTO, holidays, and busy stretches. That's when patients and pharmacies start calling to ask where their medication is, which adds even more inbound work on top of the original queue.
The question "hire or automate?" really comes down to whether your backlog is a volume problem or a capacity blip. A blip — a coding migration, a temporary vacancy — is a hiring or overtime problem. A chronic backlog from steady refill volume is a structural problem, and structural problems don't get solved by adding a linear amount of a resource that turns over.
The case for hiring more staff
Hiring has real advantages, and an honest comparison names them. A trained nurse or medical assistant brings clinical judgment automation can't replicate, handles edge cases gracefully, and can flex across other front- and back-office work when the refill queue is light. For a practice that values having a known person own the queue, that's worth something.
The limits are economic and operational. Headcount scales linearly — double the refill volume and you eventually need roughly double the staff time. And the roles that work refill queues are among the hardest to keep; back-office administrative work is a documented driver of burnout and turnover, which means a practice that hires its way out is also re-recruiting and re-training every 12 to 18 months. Each turnover event reopens the backlog you just closed.
There's also a ceiling on what hiring buys you. A new MA spends the same 30 seconds to several minutes per refill that the last one did. You're buying more of the same manual throughput, not a faster process — which is fine until volume grows again.
The case for refill automation
Automation attacks the backlog from the other direction: it removes the routine volume instead of adding capacity to absorb it. A refill processing platform reads each request, matches it to the chart and active medication list, applies your protocols, and clears the routine renewals — typically 70 to 80% of the queue — without a human touch.
The economics are different in kind, not just degree. Once configured, the platform's marginal cost per refill is near zero, so it absorbs volume growth without a matching cost increase. It doesn't take PTO, doesn't turn over, and handles the holiday surge at the same speed as a slow Tuesday. The reclaimed time is real: protocol-driven refill programs have been shown to reduce clinician workload and administrative burden precisely by shifting routine authorization off people.
The honest limits matter too. Automation needs documented protocols to work well, requires an EHR integration to set up, and never handles controlled substances or genuine clinical judgment on its own. It's a structural fix for the routine majority, not a replacement for skilled staff on the exceptions.
The ROI math, side by side
The comparison becomes concrete when you put numbers to it. Start with your own baseline: refills per day, times average minutes to handle each, times your fully loaded staff cost per minute. That's your current refill labor cost.
- Hiring converts that cost into salary plus benefits plus the recurring expense of turnover and re-training. It scales with volume — more refills, more hours, more headcount — and the cost compounds each time someone leaves.
- Automation converts most of that cost into a subscription that doesn't scale with volume the same way. The routine 70 to 80% of refills move to near-zero marginal cost; your remaining staff time concentrates on the exceptions.
The cleanest way to read it: hiring buys throughput that grows linearly with cost, automation buys throughput that's largely decoupled from cost once it's running. For a chronic, high-volume backlog, the platform usually wins on cost per refill at scale — and the gap widens as volume grows. For a small or temporary backlog, the subscription and integration effort may not pencil out against a few extra staff hours.
Why this usually isn't either/or
The framing as a binary is mostly a trap. The strongest answer for a busy practice is automation handling the routine volume and staff focused on the exceptions — each doing what it's best at.
Automation clears the protocol-eligible renewals: stable maintenance medications for patients seen within your interval. Your experienced staff stop clicking approve on every request and instead work the cases that genuinely need a person — controlled substances, patients overdue for labs or visits, dose changes, ambiguous matches. That's a better use of clinical judgment than hand-processing a queue, and it's where retention improves, because the tedious part of the job is the part people leave over.
This is the pattern Honey Health's Refill Management agent is built around: clear the in-protocol renewals automatically, flag care gaps, route controlled substances and exceptions to a human, and log every action. The platform doesn't replace your refill staff — it shrinks the queue they have to work so the same team can keep up with growing volume without you adding heads every time the panel grows.
How to decide for your practice
A few questions cut through the choice. Run them against your actual numbers, not a vendor's demo.
- Is the backlog chronic or a blip? Steady volume that outruns capacity favors automation. A one-time vacancy or migration favors overtime or a temporary hire.
- What's your refill volume trajectory? Growing volume favors automation, because hiring has to grow with it while a platform largely doesn't.
- How clean are your protocols? Well-documented standing orders mean automation can handle more on day one. Thin protocols mean you'll get less automation value until you write them down.
- What's your turnover been on these roles? High turnover makes the hiring path more expensive than the salary line suggests, and tilts the math toward automation.
The broader backdrop is real money: the 2024 CAQH Index puts the remaining savings from automating manual administrative work at roughly $20 billion a year. The refill queue is a slice of that, and the practices that claim it are the ones that stop treating a structural problem as a staffing one.
Frequently asked questions
Is it cheaper to automate refills or hire more staff?
For a sustained, high-volume refill load, automation is usually cheaper at scale because its marginal cost per refill is near zero once configured, while hiring scales linearly and carries turnover cost. For a small or short-term backlog, a few extra staff hours may be cheaper than the subscription and integration effort. Run your own refills-per-day and loaded-cost numbers to find the crossover.
Will refill automation replace my staff?
Usually not. It clears the routine 70 to 80% of refills so your existing team can focus on exceptions — controlled substances, overdue patients, dose changes, ambiguous cases. Most practices redeploy the recovered hours rather than cut roles, which also improves retention by removing the most tedious part of the job.
Can automation handle a backlog during PTO and holidays?
Yes, and that's one of its clearest advantages over hiring. A platform processes refills at the same speed regardless of who's out, so the holiday and PTO surges that normally blow up a manual queue clear at the routine rate instead. Staff coverage gaps stop translating directly into backlog.
What if our refill protocols aren't documented?
Automation works best with clear protocols, so thin documentation limits how much it can safely handle at first. The fix is to document your highest-volume, lowest-risk drug classes first, then expand. Hiring doesn't have this prerequisite, but it also can't deliver the same per-refill cost reduction.
How quickly does refill automation clear a backlog?
Most practices see the queue shrink within the first few weeks, because routine renewals stop waiting on a person. The full effect builds as protocol coverage expands across more drug classes. Hiring can move faster to add raw hours but doesn't change the per-refill processing time the way automation does.
